Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan

From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medicat...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Cheng, Chao-Neng [verfasserIn]

Li, Sin-Syue [verfasserIn]

Yeh, Yun-Hsuan [verfasserIn]

Shen, Ching-Fen [verfasserIn]

Chen, Jiann-Shiuh [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Schlagwörter:

Children

Cytomegalovirus

Hematopoietic stem cell transplantation

Letermovir

Prophylaxis

Übergeordnetes Werk:

Enthalten in: Journal of microbiology, immunology and infection - Amsterdam ˜[u.a.]œ : Elsevier, 2000, 55, Seite 323-327

Übergeordnetes Werk:

volume:55 ; pages:323-327

DOI / URN:

10.1016/j.jmii.2022.01.002

Katalog-ID:

ELV00773445X

Nicht das Richtige dabei?

Schreiben Sie uns!